-
-
Small Molecule Drug Platform
-
Chiral Catalysis Technology
-
Continuous Flow Technology
-
Fluorine Chemistry
-
Enzyme Catalysis
-
Photocatalysis
-
Solid-State Research
显示更多 -
-
Drug Product (DP) Platforms
-
Sustained and Controlled Release
-
Solubility Enhancement
-
Topical Formulation
-
Liquid Formulation
-
Softgels
-
Flow-through cell
显示更多 -
-
Peptide Platform
显示更多 -
Research Team
显示更多
-
![](/npublic/img/s.png)
Jiuzhou Pharma First Selected into the FTSE4Good Index Series
Recently, FTSE Russell (the trading name of FTSE International Limited and Frank Russell Company) confirms that Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
2024-07-15
Recently, Jiuzhou Pharmaceutical has officially joined the United Nations Global Compact (UNGC)
2024-07-08
On July 1st, the commissioning ceremony of Jiuzhou Pharmaceutical (Taizhou) Co., Ltd. was held in Taizhou Bay Economic Development Zone.
2024-07-01
2024-06-24
2024-06-20
2024-01-22
2023-11-09
2023-11-09
2023-11-09
2023-11-09
Business Collaboration
Innovative Drug CDMO Services
![Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Zhejiang Jiuzhou Pharmaceutical Co., Ltd.](https://omo-oss-image.thefastimg.com/portal-saas/new2023050917060170378/cms/image/af9820f2-7496-4bb9-a939-cbf57718f448.jpg)